RETA(Delisted)
Reata PharmaceuticalsยทNASDAQ
--
--(--)
RETA fundamentals
Reata Pharmaceuticals (RETA) released its earnings on May 8, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
May 8, 2018
EPS
Revenue
Revenue & Expenses
RETA has released its 2023 Q2 earnings report, with revenue of 22.75M, reflecting a YoY change of 2885.04%, and net profit of 193.00M, showing a YoY change of 362.39%. The Sankey diagram below clearly presents RETA's revenue sources and cost distribution.
Key Indicators
Reata Pharmaceuticals (RETA) key financial stats and ratios, covering profitability, financial health, and leverage.
Reata Pharmaceuticals (RETA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Reata Pharmaceuticals (RETA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Reata Pharmaceuticals (RETA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Reata Pharmaceuticals (RETA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Reata Pharmaceuticals (RETA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
